The companies see the collaboration as a way to help facilitate the fast, secure deployment of AI algorithms for surgical decision-making.
The NEJM paper presents data from a study of more than 10,000 people Guardant ran to support authorization of its Shield DNA test.
Lawmakers and patients have called for scrutiny of the Food and Drug Administration's medical device recall oversight after several high-profile recalls in the last five years. The U.S. Government ...
The fifth generation of the da Vinci robot offers further advancements, including tissue-sensing technology called force feedback, vibration and tremor controls, improved 3D imaging, and 10,000 times ...
The president of Medtronic’s cardiovascular portfolio talked about renal denervation, a new procedure to reduce blood pressure, and rising competition in cardiac ablation.
The agency is providing information on cybersecurity requirements for companies seeking authorization of new devices.
Fresenius sent four sets of responses to the issues the FDA raised in a Form 483 after the inspection. However, the agency ruled that some of the responses were inadequate and that it was unable to ...
The soft tissue robotics leader incorporated new features into the system, from tissue sensing feedback to a smaller size and more comfortable console.
The rating agency predicts AI will start to have a positive impact on medical device companies in the next two years.
The forecast and a small overall rise in budgets could benefit Boston Scientific, Medtronic and Stryker, BTIG analysts said.
A Food and Drug Administration advisory committee has voted that the benefits of a new agent used in Lumicell’s breast cancer imaging tool outweigh the risks.